Dr. Harry Keyserling, professor of pediatric infectious diseases at Emory School of Medicine, talks about the timeline of the pediatric H1N1 vaccine clinical trials at Emory. How do the trials relate ...
Professor Richard Gelber, Biostatistics and Computational Biology, Dana-Farber Cancer Institute Extrapolating info from clinical trials to individual patients The role of clinical trials and extrapola...
Steven K. Cheng, phd - Oregon Health and Science University, Oregan, USA. ASCO press conference: New research shows that the longer it takes to develop a cancer clinical trial, the less likely it is t...
Prof. John Smyth - Assistant Principal Cancer Research Development, University of Edinburgh Costs of licensing clinical trials Discusses the issue of the cost of licensing trials with managing editor ...
Kenneth J. Pienta, MD, director of U-Ms Michigan Institute for Clinical and Health Research, explains what is meant by randomization and why it's important in clinical trials -- particularly in Phase ...
Kenneth J. Pienta, MD, director of U-Ms Michigan Institute for Clinical and Health Research, discusses what can be done should a patient experience side effects during their participation in a clinica...